Long-term response to lithium salts in bipolar illness is influenced by the glycogen synthase kinase 3-β −50 T/C SNP
Abstract
The molecular mechanisms driving the biological clock in the suprachiasmatic nucleus of the hypothalamus may play a role in mood disorders. A single nucleotide polymorphism (SNP) (-50 T/C) falling into the effective promoter region (nt -171 to +29) of the gene coding for glycogen synthase kinase 3-beta (GSK3-beta) has been linked with different age at onset of bipolar illness and with different antidepressant effects of total sleep deprivation. GSK3-beta codes for an enzyme which is a target for the action of lithium and possibly of valproic acid. We studied the effect of this polymorphism on the therapeutic response to lithium salts of 88 bipolar type I patients. Data about recurrence rate of mood episodes were collected for at least 2 years before lithium and 2 years on lithium. Results showed that homozygotes for the wild variant did not change their recurrence index while carriers of the mutant allele improved, thus supporting the hypothesis that GSK is a target for the therapeutic action of lithium. Results warrant interest for the variants of genes pertaining to the molecular clock as possible endophenotypes of bipolar disorder, but caution ought to be taken in interpreting these preliminary results and future replication studies must be awaited because of the low frequency of the GSK3-beta*C/C genotype in the studied populations.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The GSK3β −50 T to C SNP is linked to a later age of onset of bipolar disorder.
“one of these SNPs (−50 T to C) is linked to a later age of onset of BPD and a greater response to total sleep deprivation (TSD) and long-term lithium treatment (Benedetti et al., 2004; Benedetti et al., 2005).”
From Circadian genes, rhythms and the biology of mood disorders (2007) · cites this paper as Benedetti et al., 2005
Other studies failed to show a general association between the GSK3β SNPs and bipolar disorder.
“other studies failed to show a general association between these SNPs and BPD”
From Circadian genes, rhythms and the biology of mood disorders (2007) · cites this paper as Benedetti et al., 2005
The GSK3β −50 T to C SNP is linked to a greater response to total sleep deprivation in bipolar patients.
“one of these SNPs (−50 T to C) is linked to a later age of onset of BPD and a greater response to total sleep deprivation (TSD) and long-term lithium treatment (Benedetti et al., 2004; Benedetti et al., 2005).”
From Circadian genes, rhythms and the biology of mood disorders (2007) · cites this paper as Benedetti et al., 2005
The GSK3β −50 T to C SNP is linked to a greater response to long-term lithium treatment in bipolar patients.
“one of these SNPs (−50 T to C) is linked to a later age of onset of BPD and a greater response to total sleep deprivation (TSD) and long-term lithium treatment (Benedetti et al., 2004; Benedetti et al., 2005).”
From Circadian genes, rhythms and the biology of mood disorders (2007) · cites this paper as Benedetti et al., 2005
Cites
A molecular mechanism for the effect of lithium on development.
Klein, P. S., & Melton, D. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8455 · Cited by 2,305 · see citing works
The glamour and gloom of glycogen synthase kinase-3
Jope, R. S., & Johnson, G. V. W. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2003.12.004 · Cited by 1,522 · see citing works
The multifaceted roles of glycogen synthase kinase 3β in cellular signaling
Grimes, C. A., & Jope, R. S. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(01)00011-9 · Cited by 1,429 · see citing works
Beaulieu, J., Sotnikova, T. D., Yao, W., Kockeritz, L. K., Woodgett, J. R., Gainetdinov, R. R., & Caron, M. G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307921101 · Cited by 792 · see citing works
A Role for the Segment Polarity Gene shaggy/GSK-3 in the Drosophila Circadian Clock
Martinek, S., Inonog, S., Manoukian, A. S., & Young, M. W. (2001) · Cell · doi:10.1016/s0092-8674(01)00383-x · Cited by 513 · see citing works
O'Brien, W. T., Harper, A. D., Jove, F. A., Woodgett, J. R., Maretto, S., Piccolo, S., & Klein, P. S. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.4753-03.2004 · Cited by 415 · see citing works
Chen, A. C. H., Shirayama, Y., Shin, K.-H., Neve, R. L., & Duman, R. S. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01114-8 · Cited by 314 · see citing works
Newton, S. S., Thome, J., Wallace, T. L., Shirayama, Y., Schlesinger, L., Sakai, N., Chen, J., Neve, R., Nestler, E. J., & Duman, R. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-24-10883.2002 · Cited by 313 · see citing works
Kaidanovich‐Beilin, O., Milman, A., Weizman, A., Pick, C. G., & Eldar-Finkelman, H. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.01.008 · Cited by 276 · see citing works
Endophenotypes in bipolar disorder
Lenox, R. H., Gould, T. D., & Manji, H. K. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10360 · Cited by 264 · see citing works
BDNF‐mediated signal transduction is modulated by GSK3β and mood stabilizing agents
Mai, L., Jope, R. S., & Li, X. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00939.x · Cited by 195 · see citing works
Benedetti, F., Serretti, A., Colombo, C., Lorenzi, C., Tubazio, V., & Smeraldi, E. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.06.050 · Cited by 195 · see citing works
Self-citationBenedetti, F., Bernasconi, A., Lorenzi, C., Pontiggia, A., Serretti, A., Colombo, C., & Smeraldi, E. (2003) · Neuroscience Letters · doi:10.1016/j.neulet.2003.10.021 · Cited by 162 · see citing works
Self-citationRhythms and the pharmacology of lithium
Klemfuss, H. (1992) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(92)90037-z · Cited by 134 · see citing works
Search for a common mechanism of mood stabilizers
Harwood, A. J., & Agam, G. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00187-4 · Cited by 132 · see citing works
Expression analysis of glycogen synthase kinase‐3 in human tissues
Lau, K., Miller, C. C. J., Anderton, B. H., & Shaw, P. C. (1999) · Journal of Peptide Research · doi:10.1034/j.1399-3011.1999.00083.x · Cited by 113 · see citing works
Early onset of lithium prophylaxis as a predictor of good long-term outcome
Franchini, L., Zanardi, R., Smeraldi, E., & Gasperini, M. (1999) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s004060050091 · Cited by 113 · see citing works
Self-citationGasparini, P., Estivill, X., Volpini, V., Totaro, A., Castellvı́-Bel, S., Govea, N., Milà, M., Monica, M. D., Ventruto, N. V., Benedetto, M. D., et al. (1997) · PubMed · Cited by 108 · see citing works
Totaro, A., P., G., Estivill, X., Volpini, V., Castellvı́-Bel, S., Govea, N., Milà, M., Monica, M. D., Ventruto, V., Benedetto, M. D., et al. (1997) · European Journal of Human Genetics · doi:10.1159/000484738 · Cited by 105 · see citing works
Iwahana, E., Akiyama, M., Miyakawa, K., Uchida, A., Kasahara, J., Fukunaga, K., Hamada, T., & Shibata, S. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03322.x · Cited by 103 · see citing works
Badenhop, R. F., Moses, M. J., Scimone, A., Mitchell, P. B., Ewen-White, K. R., Rosso, A., Donald, J. A., Adams, L. J., & Schofield, P. R. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001025 · Cited by 73 · see citing works
Molecular Cloning and Characterization of the Human Glycogen Synthase Kinase-3β Promoter
Lau, K., Miller, C. C. J., Anderton, B. H., & Shaw, P. (1999) · Genomics · doi:10.1006/geno.1999.5875 · Cited by 67 · see citing works
Glycogen synthase kinase-3β, β-catenin, and tau in postmortem bipolar brain
Lesort, M. J., Greendorfer, A., Stockmeier, C. A., Johnson, G. V. W., & Jope, R. S. (1999) · Journal of Neural Transmission · doi:10.1007/s007020050235 · Cited by 62 · see citing works
Badenhop, R. F., Moses, M. J., Scimone, A., Mitchell, P. B., Ewen-White, K. R., Rosso, A., Donald, J. A., Adams, L. J., & Schofield, P. R. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001114 · Cited by 61 · see citing works
Russ, C., Lovestone, S., & Powell, J. F. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000852 · Cited by 60 · see citing works
Vestergaard, P., Licht, R. W., Brodersen, A., Rasmussen, N. A., Christensen, H., Arngrim, T., Grønvall, B., Kristensen, E., & Poulstrup, I. (1998) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1998.tb10089.x · Cited by 59 · see citing works
Effects of lithium ions on glycogen synthase and phosphorylase in rat hepatocytes.
Bosch, F., Gómèz‐Foix, A. M., Ariño, J., & Guinovart, J. J. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)75978-x · Cited by 50 · see citing works
Hansen, L., Arden, K. C., Rasmussen, S., Viars, C. S., Vestergaard, H., Hansen, T. F., Møller, A. M., Woodgett, J. R., & Pedersen, O. B. (1997) · Diabetologia · doi:10.1007/s001250050771 · Cited by 39 · see citing works
Antimanic drugs stabilize hamster circadian rhythms
Klemfuss, H., & Kripke, D. F. (1995) · Psychiatry Research · doi:10.1016/0165-1781(95)02687-r · Cited by 35 · see citing works
Predicting Response to Lithium in Mood Disorders
Serretti, A., & Artioli, P. (2003) · American Journal of PharmacoGenomics · doi:10.2165/00129785-200303010-00004 · Cited by 29 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases
Beurel, E., Grieco, S. F., & Jope, R. S. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.016 · Cited by 1,768 · see citing works
Circadian genes, rhythms and the biology of mood disorders
McClung, C. A. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.02.003 · Cited by 666 · see citing works
Bauer, M., Pfennig, A., Severus, E., Whybrow, P. C., Angst, J., Möller, H.-J., & Šon behalf of the Task Force on Unipolar Depressive Disorders (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2013.804195 · Cited by 632 · see citing works
Glycogen Synthase Kinase-3: a Putative Molecular Target for Lithium Mimetic Drugs
Gould, T. D., & Manji, H. K. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300731 · Cited by 377 · see citing works
Clarifying the role of sleep in depression: A narrative review
Pandi-Perumal, S. R., Monti, J. M., Burman, D., Ramanujam, K., BaHammam, A. S., Spence, D. W., Brown, G. M., & Narashimhan, M. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113239 · Cited by 335 · see citing works
Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics
Alda, M. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.4 · Cited by 317 · see citing works
Is Glycogen Synthase Kinase-3 a Central Modulator in Mood Regulation?
Li, X., & Jope, R. S. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.105 · Cited by 294 · see citing works
The role of circadian clock genes in mental disorders
Lamont, E. W., Coutu, D. L., Cermakian, N., & Boivin, D. B. (2007) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2007.9.3/elamont · Cited by 224 · see citing works
The ups and downs of Wnt signaling in prevalent neurological disorders
Ferrari, G. V. D., & Moon, R. T. (2006) · Oncogene · doi:10.1038/sj.onc.1210064 · Cited by 221 · see citing works
Sleep Disturbance in Bipolar Disorder: Therapeutic Implications
Plante, D. T., & Winkelman, J. W. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08010077 · Cited by 268 · see citing works
Clock genes may influence bipolar disorder susceptibility and dysfunctional circadian rhythm
Shi, J., Wittke‐Thompson, J. K., Badner, J. A., Hattori, E., Potash, J. B., Willour, V. L., McMahon, F. J., Gershon, E. S., & Liu, C. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30714 · Cited by 211 · see citing works
Benedetti, F., Dallaspezia, S., Fulgosi, M. C., Lorenzi, C., Serretti, A., Barbini, B., Colombo, C., & Smeraldi, E. (2007) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30475 · Cited by 205 · see citing works
Self-citationThe circadian basis of mood disorders: Recent developments and treatment implications
Monteleone, P., & Maj, M. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.06.007 · Cited by 185 · see citing works
Glycogen Synthase Kinase-3 in the Etiology and Treatment of Mood Disorders
Jope, R. S. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00016 · Cited by 174 · see citing works
Mármol, F. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.08.012 · Cited by 174 · see citing works
Opposite effects of suicidality and lithium on gray matter volumes in bipolar depression
Benedetti, F., Radaelli, D., Poletti, S., Locatelli, C., Falini, A., Colombo, C., & Smeraldi, E. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.07.006 · Cited by 165 · see citing works
Self-citationCircadian rhythms and treatment implications in depression
Monteleone, P., Martiadis, V., & Maj, M. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.07.028 · Cited by 165 · see citing works
Lithium and GSK3-β Promoter Gene Variants Influence White Matter Microstructure in Bipolar Disorder
Benedetti, F., Bollettini, I., Barberi, I., Radaelli, D., Poletti, S., Locatelli, C., Pirovano, A., Lorenzi, C., Falini, A., Colombo, C., et al. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.172 · Cited by 164 · see citing works
Self-citationGSK3β: role in therapeutic landscape and development of modulators
Phukan, S., Babu, V. V., Kannoji, A., Hariharan, R., & Balaji, V. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00661.x · Cited by 160 · see citing works
Peterson, M. J., & Benca, R. M. (2006) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2006.09.003 · Cited by 164 · see citing works
A length polymorphism in the circadian clock gene Per3 influences age at onset of bipolar disorder
Benedetti, F., Dallaspezia, S., Colombo, C., Pirovano, A., Marino, E., & Smeraldi, E. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.09.002 · Cited by 149 · see citing works
Self-citationGSK-3 is a viable potential target for therapeutic intervention in bipolar disorder
Rowe, M. K., Wiest, C., & Chuang, D. (2007) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2007.03.002 · Cited by 142 · see citing works
McCarthy, M. J., Wei, H., Marnoy, Z., Darvish, R. M., McPhie, D. L., Cohen, B. M., & Welsh, D. K. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.90 · Cited by 137 · see citing works
β-Catenin Overexpression in the Mouse Brain Phenocopies Lithium-Sensitive Behaviors
Gould, T. D., Einat, H., O’Donnell, K. C., Picchini, A. M., Schloesser, R. J., & Manji, H. K. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301338 · Cited by 137 · see citing works
Glycogen Synthase Kinase-3 Inhibitors: Preclinical and Clinical Focus on CNS-A Decade Onward
Ruiz, S. M. A., & Eldar-Finkelman, H. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.792364 · Cited by 126 · see citing works
ASsociation of gsk3β polymorphisms with brain structural changes in major depressive disorder
Inkster, B., Nichols, T. E., Saemann, P. G., Auer, D. P., Holsboer, F., Muglia, P., & Matthews, P. M. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.70 · Cited by 127 · see citing works
Kaladchibachi, S., Doble, B. W., Anthopoulos, N., Woodgett, J. R., & Manoukian, A. S. (2007) · Journal of Circadian Rhythms · doi:10.1186/1740-3391-5-3 · Cited by 128 · see citing works
Increase in GSK3β gene copy number variation in bipolar disorder
Lachman, H. M., Pedrosa, E., Petruolo, O. A., Cockerham, M. S., Papolos, A., Novák, T., Papolos, D. F., & Stopková, P. (2007) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30498 · Cited by 127 · see citing works
Biological rhythms, higher brain function, and behavior: Gaps, opportunities, and challenges
Benca, R., Duncan, M. J., Frank, E., McClung, C., Nelson, R. J., & Vicentic, A. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2009.09.005 · Cited by 125 · see citing works
Role of Lithium Augmentation in the Management of Major Depressive Disorder
Bauer, M., Adli, M., Ricken, R., Severus, E., & Pilhatsch, M. (2014) · CNS Drugs · doi:10.1007/s40263-014-0152-8 · Cited by 123 · see citing works
Molecular actions and clinical pharmacogenetics of lithium therapy
Can, A., Schulze, T. G., & Gould, T. D. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.02.004 · Cited by 121 · see citing works
Bauer, M., Adli, M., Bschor, T., Pilhatsch, M., Pfennig, A., Sasse, J., Schmid, R., & Lewitzka, U. (2010) · Neuropsychobiology · doi:10.1159/000314308 · Cited by 120 · see citing works
Lee, K. W., Woon, P. S., Teo, Y. Y., & Sim, K. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.09.001 · Cited by 117 · see citing works
Intracellular pathways underlying the effects of lithium
Pasquali, L., Busceti, C. L., Fulceri, F., Paparelli, A., & Fornai, F. (2010) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32833da5da · Cited by 112 · see citing works
Le-Niculescu, H., McFarland, M. J., Ogden, C. A., Balaraman, Y., Patel, S. D., Tan, J., Rodd, Z. A., Paulus, M. P., Geyer, M. A., Edenberg, H. J., et al. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30707 · Cited by 108 · see citing works
Sleep- and circadian rhythm–associated pathways as therapeutic targets in bipolar disorder
Bellivier, F., Geoffroy, P.-A., Etain, B., & Scott, J. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2015.1018822 · Cited by 104 · see citing works
Michelon, L., Meira-Lima, I., Cordeiro, Q., Miguita, K., Breen, G., Collier, D., & Vallada, H. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.05.001 · Cited by 104 · see citing works
Adli, M., Hollinde, D. L., Stamm, T. J., Wiethoff, K., Tsahuridu, M., Kirchheiner, J., Heinz, A., & Bauer, M. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.03.023 · Cited by 100 · see citing works
Peripheral Circadian Oscillators
Cuninkova, L., & Brown, S. A. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1417.005 · Cited by 101 · see citing works
McCarthy, M. J., Nievergelt, C. M., Shekhtman, T., Kripke, D. F., Welsh, D. K., & Kelsoe, J. R. (2011) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2011.00725.x · Cited by 97 · see citing works
Translational research in bipolar disorder: emerging insights from genetically based models
Chen, G., Henter, I. D., & Manji, H. K. (2010) · Molecular Psychiatry · doi:10.1038/mp.2010.3 · Cited by 95 · see citing works
Inflammation in Bipolar Disorder (BD): Identification of new therapeutic targets
Pereira, A. C., Oliveira, J. M., Silva, S., Madeira, N. G. G. F., Pereira, C., & Cruz, M. T. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105325 · Cited by 96 · see citing works
Lithium and bipolar disorder: Impacts from molecular to behavioural circadian rhythms
Moreira, J., & Geoffroy, P. A. (2016) · Chronobiology International · doi:10.3109/07420528.2016.1151026 · Cited by 95 · see citing works
Squassina, A., Manchia, M., Borg, J., Congiu, D., Costa, M. F., Georgitsi, M., Chillotti, C., Ardau, R., Mitropoulos, K. A., Severino, G., et al. (2011) · Pharmacogenomics · doi:10.2217/pgs.11.102 · Cited by 93 · see citing works
Response to Lithium in Bipolar Disorder: Clinical and Genetic Findings
RYBAKOWSKI, J. K. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn5000277 · Cited by 88 · see citing works
Circadian biomarkers, circadian genes and bipolar disorders
Milhiet, V., Étain, B., Boudebesse, C., & Bellivier, F. (2011) · Journal of Physiology-Paris · doi:10.1016/j.jphysparis.2011.07.002 · Cited by 87 · see citing works
Behavioural sensitization to repeated sleep deprivation in a mice model of mania
BENEDETTI, F., FRESI, F., MACCIONI, P., & SMERALDI, E. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.09.012 · Cited by 85 · see citing works
Self-citation[Circadian rhythms and depression].
Soria, V., & Urretavizcaya, M. (2009) · PubMed · Cited by 83 · see citing works
Sleep Deprivation Therapy for Depression
Dallaspezia, S., & Benedetti, F. (2014) · Current topics in behavioral neurosciences · doi:10.1007/7854_2014_363 · Cited by 83 · see citing works
Self-citationPharmacogenetics of Lithium Response in Bipolar Disorder
McCarthy, M. J., Leckband, S. G., & Kelsoe, J. R. (2010) · Pharmacogenomics · doi:10.2217/pgs.10.127 · Cited by 78 · see citing works
Genetic Influences on Response to Mood Stabilizers in Bipolar Disorder
RYBAKOWSKI, J. K. (2013) · CNS Drugs · doi:10.1007/s40263-013-0040-7 · Cited by 79 · see citing works
Lee, K. Y., Song, J. Y., Kim, S. H., Kim, S. C., Joo, E.-J., Ahn, Y. M., & Kim, Y. S. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.06.010 · Cited by 79 · see citing works
Polymorphism of circadian clock genes and prophylactic lithium response
RYBAKOWSKI, J. K., Dmitrzak‐Węglarz, M., Kliwicki, S., & Hauser, J. (2013) · Bipolar Disorders · doi:10.1111/bdi.12136 · Cited by 78 · see citing works
Melatonin, circadian rhythms, and the clock genes in bipolar disorder
Dallaspezia, S., & Benedetti, F. (2009) · Current Psychiatry Reports · doi:10.1007/s11920-009-0074-1 · Cited by 77 · see citing works
Self-citationSzczepankiewicz, A., RYBAKOWSKI, J. K., Suwalska, A., Skibińska, M., Leszczyńska-Rodziewicz, A., Dmitrzak‐Węglarz, M., Czerski, P. M., & Hauser, J. (2006) · The World Journal of Biological Psychiatry · doi:10.1080/15622970600554711 · Cited by 73 · see citing works
Machado‐Vieira, R., Soeiro‐de‐Souza, M. G., Richards, E. M., Teixeira, A. L., & Zarate, C. A. (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2013.830775 · Cited by 70 · see citing works
Glycogen synthase kinase 3 substrates in mood disorders and schizophrenia
Cole, A. R. (2013) · FEBS Journal · doi:10.1111/febs.12407 · Cited by 69 · see citing works
Prediction of response to drug therapy in psychiatric disorders
Stern, S., Linker, S. B., Vadodaria, K. C., Marchetto, M. C., & Gage, F. H. (2018) · Open Biology · doi:10.1098/rsob.180031 · Cited by 65 · see citing works
O’Leary, O. F., & Nolan, Y. M. (2014) · CNS Drugs · doi:10.1007/s40263-014-0213-z · Cited by 63 · see citing works
Lin, K., Huang, M., & Liu, H. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.08.025 · Cited by 62 · see citing works
Machado‐Vieira, R. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.12.026 · Cited by 62 · see citing works
Benedetti, F., & Smeraldi, E. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209788957447 · Cited by 60 · see citing works
Self-citationBenedetti, F., Poletti, S., Radaelli, D., Bernasconi, A., Cavallaro, R., Falini, A., Lorenzi, C., Pirovano, A., Dallaspezia, S., Locatelli, C., et al. (2010) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2010.00566.x · Cited by 59 · see citing works
Self-citationGenetic Factors Affecting Seasonality, Mood, and the Circadian Clock
Garbazza, C., & Benedetti, F. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00481 · Cited by 55 · see citing works
Self-citationThe Wnt Pathway in Mood Disorders
Sani, G., Napoletano, F., Forte, A. M., Kotzalidis, G. D., Panaccione, I., Porfiri, G. M., Simonetti, A., Caloro, M., Girardi, N., Telesforo, C. L., et al. (2012) · Current Neuropharmacology · doi:10.2174/157015912803217279 · Cited by 55 · see citing works
Lee, K. Y., Ahn, Y. M., Joo, E.-J., Jeong, S.-H., Chang, J. S., Kim, S.-C., & Kim, Y. S. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.10.059 · Cited by 54 · see citing works
Lithium's role in neural plasticity and its implications for mood disorders
Gray, J. D., & McEwen, B. S. (2013) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12139 · Cited by 54 · see citing works
Chronobiology of Bipolar Disorder: Therapeutic Implication
Dallaspezia, S., & Benedetti, F. (2015) · Current Psychiatry Reports · doi:10.1007/s11920-015-0606-9 · Cited by 53 · see citing works
Self-citationSaus, E., Soria, V., Escaramís, G., Crespo, J. M., Valero, J., Gutiérrez‐Zotes, A., Martorell, L., Vilella, E., Menchón, J. M., Estivill, X., et al. (2010) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2010.00617.x · Cited by 51 · see citing works
The Promise and Reality of Pharmacogenetics in Psychiatry
Zandi, P. P., & Judy, J. (2010) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2009.12.001 · Cited by 51 · see citing works
Benedetti, F., Dallaspezia, S., Lorenzi, C., Pirovano, A., Radaelli, D., Locatelli, C., Poletti, S., Colombo, C., & Smeraldi, E. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.10.039 · Cited by 49 · see citing works
Self-citationAntidepressant chronotherapeutics for bipolar depression
Benedetti, F. (2012) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2012.14.4/fbenedetti · Cited by 49 · see citing works
Self-citationTomasetti, C., Dell’Aversano, C., Iasevoli, F., Marmo, F., & de Bartolomeis, A. (2011) · Progress in Neuro-psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.10.025 · Cited by 49 · see citing works
The Role of Pharmacogenomics in Bipolar Disorder: Moving Towards Precision Medicine
Pisanu, C., Heilbronner, U., & Squassina, A. (2018) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-018-0335-y · Cited by 48 · see citing works
Stargazin involvement with bipolar disorder and response to lithium treatment
Silberberg, G., Levit, A., Collier, D. A., Clair, D. S., Munro, J., Kerwin, R. W., Tondo, L., Floris, G., Breen, G. D., & Navon, R. (2008) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3282f974ca · Cited by 48 · see citing works
Peterson, M. J., & Benca, R. M. (2008) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2008.01.009 · Cited by 47 · see citing works
Geoffroy, P. A., Boudebesse, C., Henrion, A., Jamain, S., Henry, C., Leboyer, M., Bellivier, F., & Étain, B. (2013) · Genes Brain & Behavior · doi:10.1111/gbb.12103 · Cited by 46 · see citing works
Higgins, G. A., Allyn-Feuer, A., Barbour, E., & Athey, B. D. (2015) · Pharmacogenomics · doi:10.2217/pgs.15.106 · Cited by 46 · see citing works
Lithium: a key to the genetics of bipolar disorder
Cruceanu, C., Alda, M., & Turecki, G. (2009) · Genome Medicine · doi:10.1186/gm79 · Cited by 45 · see citing works
de Bartolomeis, A., Buonaguro, E. F., Iasevoli, F., & Tomasetti, C. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114523864 · Cited by 44 · see citing works
Circadian clocks, brain function, and development
Frank, E., Sidor, M. M., Gamble, K. L., Cirelli, C., Sharkey, K. M., Hoyle, N. P., Tikotzky, L., Talbot, L. S., McCarthy, M. J., & Hasler, B. P. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12335 · Cited by 45 · see citing works
Serretti, A., Benedetti, F., Mandelli, L., Calati, R., Caneva, B., Lorenzi, C., Fontana, V., Colombo, C., & Smeraldi, E. (2007) · Psychiatry Research · doi:10.1016/j.psychres.2007.06.017 · Cited by 43 · see citing works
Self-citationKim, K.-H., Liu, J., Galvin, R. J. S., Dage, J., Egeland, J., Smith, R. C., Merchant, K. M., & Paul, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142693 · Cited by 36 · see citing works
Iwahashi, K., Nishizawa, D., Narita, S., Numajiri, M., Murayama, O., Yoshihara, E., Onozawa, Y., Nagahori, K., Fukamauchi, F., Ikeda, K., et al. (2014) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000039 · Cited by 40 · see citing works
Targeting glycogen synthase kinase-3 as an approach to develop novel mood-stabilising medications
Gould, T. D. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.3.377 · Cited by 40 · see citing works
Pharmacogenetic considerations in the treatment of psychiatric disorders
Lohoff, F. W., & Ferraro, T. N. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903508762 · Cited by 38 · see citing works
Pharmacogenomic aspects of bipolar disorder: An update
Budde, M., Degner, D., Brockmöller, J., & Schulze, T. G. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.02.001 · Cited by 38 · see citing works
Sleep and biorythm disturbances in schizophrenia, mood and anxiety disorders: a review
Bersani, F. S., Iannitelli, A., Pacitti, F., & Bersani, G. (2012) · Rivista di psichiatria · doi:10.1708/1175.13027 · Cited by 37 · see citing works
Signaling Pathways Involved in Antidepressant-Induced Cell Proliferation and Synaptic Plasticity
Pilar-Cuéllar, F., Vidal, R., Díaz, Á., Castro, E., Dos-Anjos, S., Vargas, V. I., Romero, B., & Valdizán, E. M. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113196660736 · Cited by 36 · see citing works
Lithium and GSK-3β promoter gene variants influence cortical gray matter volumes in bipolar disorder
Benedetti, F., Poletti, S., Radaelli, D., Locatelli, C., Pirovano, A., Lorenzi, C., Vai, B., Bollettini, I., Falini, A., Smeraldi, E., et al. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3770-4 · Cited by 37 · see citing works
Self-citationSynapsin II Is Involved in the Molecular Pathway of Lithium Treatment in Bipolar Disorder
Cruceanu, C., Alda, M., Grof, P., Rouleau, G. A., & Turecki, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032680 · Cited by 36 · see citing works
Genetic association of BDNF val66met and GSK‐3β‐50T/C polymorphisms with tardive dyskinesia
Park, S. W., Lee, J. G., Kong, B. G., Lee, S. J., Lee, C. H., Kim, J. I., & Kim, Y. H. (2009) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2009.01976.x · Cited by 35 · see citing works
Luykx, J. J., Boks, M. P., Terwindt, A. P. R., Bakker, S. C., Kahn, R. S., & Ophoff, R. A. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.02.008 · Cited by 32 · see citing works
Twenty years of Lithium pharmacogenetics: A systematic review
Pagani, R., Gasparini, A., Ielmini, M., Caselli, I., Poloni, N., Ferrari, M., Marino, F., & Callegari, C. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.05.036 · Cited by 32 · see citing works
Mood and behavior regulation: interaction of lithium and dopaminergic system
Mohamadian, M., Fallah, H., Ghofrani-Jahromi, Z., Rahimi-Danesh, M., Saadlou, M.-S. S. Q., & Vaseghi, S. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02437-1 · Cited by 32 · see citing works
Pharmacogenomics of Bipolar Disorder
Severino, G., Squassina, A., Costa, M. F., Pisanu, C., Calza, S., Alda, M., Zompo, M. D., & Manchia, M. (2013) · Pharmacogenomics · doi:10.2217/pgs.13.51 · Cited by 30 · see citing works
Towards the clinical implementation of pharmacogenetics in bipolar disorder
Salloum, N. C., McCarthy, M. J., Leckband, S. G., & Kelsoe, J. R. (2014) · BMC Medicine · doi:10.1186/1741-7015-12-90 · Cited by 30 · see citing works
Squassina, A., Congiu, D., Manconi, F., Manchia, M., Chillotti, C., Lampus, S. F., Severino, G., & Zompo, M. D. (2008) · Pharmacological Research · doi:10.1016/j.phrs.2008.03.011 · Cited by 30 · see citing works
β-Catenin Promoter ChIP-Chip Reveals Potential Schizophrenia and Bipolar Disorder Gene Network
Pedrosa, E., Shah, A., Tenore, C., Capogna, M., Villa, C., Guo, X., Zheng, D., & Lachman, H. M. (2010) · Journal of Neurogenetics · doi:10.3109/01677063.2010.495182 · Cited by 29 · see citing works
Association analysis of the glycogen synthase kinase-3β gene in bipolar disorder
Nishiguchi, N., Breen, G. D., Russ, C., Clair, D. S., & Collier, D. A. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.10.042 · Cited by 29 · see citing works
- Authors
- Benedetti, F., Serretti, A., Pontiggia, A., Bernasconi, A., Lorenzi, C., Colombo, C., & Smeraldi, E.
- Affiliations
- Vita-Salute San Raffaele University (IT)
- IRCCS Ospedale San Raffaele (IT)
- Corresponding author
- Benedetti, Francesco
- Venue
- Neuroscience Letters
- Publisher
- Elsevier BV
- Published
- 2005-03
- Volume
- 376
- Issue
- 1
- Pages
- 51-55
- ISSN
- 0304-3940 (ISSN-L)
- OpenAlex
- W2078634434
- Cited by
- 184
- References
- 30
- Citations by year
- 2026: 3 · 2025: 3 · 2023: 3 · 2022: 7 · 2020: 8 · 2019: 9 · 2018: 7 · 2017: 3 · 2016: 7 · 2015: 8 · 2014: 15 · 2013: 16 · 2012: 13
- FWCI
- 4.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuroscience Letters (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Keywords
- lithium response, bipolar I disorder, glycogen synthase kinase-3β, promoter polymorphism, genetic susceptibility, mood episode recurrence, molecular clock, endophenotypes, valproic acid, age of onset
- MeSH terms
- Glycogen Synthase Kinase 3 beta, Adult, Analysis of Variance, Bipolar Disorder, DNA Mutational Analysis, Female, Humans, Lithium, Male, Middle Aged, Pharmacogenetics, Promoter Regions, Genetic, RNA, Messenger, Time, Time Factors, Reverse Transcriptase Polymerase Chain Reaction, Polymorphism, Single Nucleotide, Glycogen Synthase Kinase 3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review